Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

514 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Neutrophil to lymphocyte ratio (NTLR) predicts local control and overall survival after stereotactic body radiotherapy (SBRT) in metastatic sarcoma.
Somasundaram E, Anderson PM, Smile TD, Halima A, Broughman JB, Reddy CA, Parsai S, Scott JG, Chan T, Campbell S, Angelov L, Zahler S, Trucco M, Thomas SM, Johnson S, Qi P, Magnelli A, Murphy ES. Somasundaram E, et al. Among authors: trucco m. Sci Rep. 2023 Nov 7;13(1):19256. doi: 10.1038/s41598-023-46476-3. Sci Rep. 2023. PMID: 37935813 Free PMC article.
Neutrophil to Lymphocyte Ratio (NTLR) Predicts Local Control Failure and Overall Survival after Stereotactic Body Radiotherapy (SBRT) In Metastatic Sarcoma.
Somasundaram E, Smile TD, Halima A, Broughman JB, Reddy CA, Parsai S, Scott JG, Chan T, Campbell S, Angelov L, Zahler S, Trucco M, Thomas SM, Johnson S, Qi P, Magnelli A, Anderson PM, Murphy ES. Somasundaram E, et al. Among authors: trucco m. Res Sq [Preprint]. 2023 Jun 8:rs.3.rs-2570832. doi: 10.21203/rs.3.rs-2570832/v1. Res Sq. 2023. Update in: Sci Rep. 2023 Nov 7;13(1):19256. doi: 10.1038/s41598-023-46476-3 PMID: 37333401 Free PMC article. Updated. Preprint.
Association between biologically effective dose and local control after stereotactic body radiotherapy for metastatic sarcoma.
Somasundaram E, D Smile T, Halima A, Broughman JB, Reddy CA, Parsai S, Scott JG, Shah C, Chan T, Campbell S, Angelov L, Anderson PM, Zahler S, Trucco M, Thomas SM, Johnson S, Mesko N, Nystrom L, Shepard D, Budd GT, Qi P, Magnelli A, Murphy ES. Somasundaram E, et al. Among authors: trucco m. J Radiosurg SBRT. 2022;8(4):265-273. J Radiosurg SBRT. 2022. PMID: 37416333 Free PMC article.
Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing Sarcoma.
Meyers PA, Federman N, Daw N, Anderson PM, Davis LE, Kim A, Macy ME, Pietrofeso A, Ratan R, Riedel RF, Trucco M, Breitmeyer JB, Toretsky JA, Ludwig JA. Meyers PA, et al. Among authors: trucco m. J Clin Oncol. 2024 Nov;42(31):3725-3734. doi: 10.1200/JCO.24.00020. Epub 2024 Jul 2. J Clin Oncol. 2024. PMID: 38954782 Clinical Trial.
DNA Methylation Profiling Distinguishes Adamantinoma-Like Ewing Sarcoma From Conventional Ewing Sarcoma.
Fritchie KJ, Ameline B, Andrei V, Griffith C, Shah AA, Dermawan JK, Trucco M, Budd T, Thangaiah JJ, Molligan J, Whaley RD, Magliocca K, Azzato E, van Zante A, Jo V, Xu B, Bishop JA, Rooper L, Baumhoer D. Fritchie KJ, et al. Among authors: trucco m. Mod Pathol. 2023 Nov;36(11):100301. doi: 10.1016/j.modpat.2023.100301. Epub 2023 Aug 9. Mod Pathol. 2023. PMID: 37567448 Free PMC article.
Novel PAX3::MAML3 Fusion Identified in Alveolar Rhabdomyosarcoma, Using DNA Methylation Profiling to Expand the Genetic Spectrum of "Fusion-Positive" Cases.
Dermawan JK, Malik F, Gross JM, Baraban E, Pratilas C, Mneimneh W, Trucco M, Sun W, Barr FG, D'Almeida Costa F, Fritchie KJ. Dermawan JK, et al. Among authors: trucco m. Mod Pathol. 2024 Nov;37(11):100594. doi: 10.1016/j.modpat.2024.100594. Epub 2024 Aug 13. Mod Pathol. 2024. PMID: 39147032 Free article.
Phase II Trial of Gemcitabine and Nab-Paclitaxel for Recurrent Osteosarcoma with Serial Monitoring Using Liquid Biopsy: A Report from the National Pediatric Cancer Foundation.
Dhir A, Hayashi M, Bodlak A, Oesterheld J, Loeb DM, Mascarenhas L, Isakoff MS, Sandler ES, Borinstein SC, Trucco M, Lagmay JP, Setty BA, Pratilas CA, Caywood E, Metts J, Yin H, Fridley B, Yin J, Laborde J, Reed DR, Adams DL, Wagner LM. Dhir A, et al. Among authors: trucco m. Clin Cancer Res. 2024 Dec 2;30(23):5314-5322. doi: 10.1158/1078-0432.CCR-24-1339. Clin Cancer Res. 2024. PMID: 39360936 Clinical Trial.
Consensus recommendations for systemic therapies in the management of relapsed Ewing sarcoma: A report from the National Ewing Sarcoma Tumor Board.
Gupta A, Dietz MS, Riedel RF, Dhir A, Borinstein SC, Isakoff MS, Aye JM, Rainusso N, Armstrong AE, DuBois SG, Wagner LM, Rosenblum JM, Cohen-Gogo S, Albert CM, Zahler S, Chugh R, Trucco M. Gupta A, et al. Among authors: trucco m. Cancer. 2024 Dec 1;130(23):4028-4039. doi: 10.1002/cncr.35537. Epub 2024 Aug 25. Cancer. 2024. PMID: 39182183 Review.
514 results